KevinMD January 17, 2021
Betty Rabinowitz, MD

Developing the COVID-19 vaccine was the first monumental milestone on a long and arduous journey to achieving the entire U.S. population’s vaccination.

One of the barriers to achieving this task is the absence of a reliable, scalable way to uniquely identify each individual before or after they receive the vaccine. Furthermore, in the absence of this unique identifier, it is extremely difficult to reliably use existing state or regional data repositories to identify and prioritize vaccination of individuals who share clinical and demographic characteristics that put them at high risk for COVID-19 morbidity or mortality.

As patients traverse the health care system, they frequently “touch” multiple organizations, and as a result, there is a significant overlap in the patient records...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: EMR / EHR, Govt Agencies, Health IT, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Technology
GLP1 Drugs Not Tied to Pregnancy Loss, Birth Defects
Mental health treatment plan goals: Setting providers and patients up for success
High board exam scores linked to reduced patient deaths
62 percent of young adults wouldn't live in state with abortion ban: Survey
STAT+: Young boy dies in trial for Pfizer Duchenne gene therapy

Share This Article